Overview

Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer

Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to improve their outcome by either changing the chemotherapy drugs or giving them radiation therapy with concurrent chemotherapy, hoping that this will improve their outcome.
Phase:
Phase 2
Details
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Treatments:
Camptothecin
Cisplatin
Docetaxel
Fluorouracil
Irinotecan